TIAA CREF INVESTMENT MANAGEMENT LLC - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 81 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.38 and the average weighting 0.1%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$691,000
+92.5%
213,942
-19.4%
0.00%
Q4 2016$359,000
-8.2%
265,558
+5.9%
0.00%
Q3 2016$391,000
+64.3%
250,879
+40.4%
0.00%
Q2 2016$238,000
-71.0%
178,736
+14.7%
0.00%
-100.0%
Q1 2016$821,000
-57.6%
155,864
-36.8%
0.00%0.0%
Q4 2015$1,935,000
-36.2%
246,514
-31.4%
0.00%
-50.0%
Q3 2015$3,035,000
-25.6%
359,204
-3.6%
0.00%
-33.3%
Q2 2015$4,079,000
-17.3%
372,536
+5.6%
0.00%0.0%
Q1 2015$4,930,000
+18.9%
352,633
+43.6%
0.00%0.0%
Q4 2014$4,147,000
+72.3%
245,557
+36.9%
0.00%
+50.0%
Q3 2014$2,407,000
+2.4%
179,333
-2.8%
0.00%0.0%
Q2 2014$2,351,000
+6.6%
184,565
-0.5%
0.00%0.0%
Q1 2014$2,206,000
-14.9%
185,558
-1.2%
0.00%0.0%
Q4 2013$2,593,000
-22.5%
187,798
-2.0%
0.00%
-33.3%
Q3 2013$3,346,000
+5.7%
191,726
-1.6%
0.00%0.0%
Q2 2013$3,167,000194,8630.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
BVF INC/IL 17,426,968$36,945,0001.45%
Opaleye Management Inc. 3,171,800$6,724,0000.88%
EAM Investors, LLC 421,103$893,0000.15%
Bleichroeder LP 250,000$530,0000.10%
PLATINUM INVESTMENT MANAGEMENT LTD 755,593$1,602,0000.04%
Callan Capital, LLC 73,200$155,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 419,300$889,0000.02%
Private Wealth Advisors, Inc. 12,000$25,0000.01%
Alpine Global Management, LLC 24,575$52,0000.01%
Evercore Wealth Management, LLC 143,138$303,0000.01%
View complete list of INFINITY PHARMACEUTICALS INC shareholders